Literature DB >> 2010646

Protective and curative effects of rifampicin in Acanthamoeba meningitis of the mouse.

S R Das1, S Asiri, A el-Soofi, H P Baer.   

Abstract

BALB/c mice inoculated nasally with Acanthamoeba culbertsoni, resulting in amebic encephalitis and death 3-7 days, were treated with rifampicin prophylactically (daily for 2 days with 75 and 100 mg/kg) and after infection (daily for 5 days with doses of 10-100 mg/kg). Prophylactic treatment resulted in full protection against infection, as assessed by absence of symptoms of central nervous system malfunction and negative brain culture 10 days after inoculation. Curative treatment was effective at the same doses; however, at doses of 10, 25, and 50 mg/kg, only two of six animals were free of symptoms and infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2010646     DOI: 10.1093/infdis/163.4.916

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Acute granulomatous acanthamoeba encephalitis in an immunocompetent patient.

Authors:  Peter Lackner; Ronny Beer; Gregor Broessner; Raimund Helbok; Bettina Pfausler; Christian Brenneis; Herbert Auer; Julia Walochnik; Erich Schmutzhard
Journal:  Neurocrit Care       Date:  2010-02       Impact factor: 3.210

Review 2.  Acanthamoeba spp. as agents of disease in humans.

Authors:  Francine Marciano-Cabral; Guy Cabral
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.